XC e XC e
F- w F- w
PD
PD
er
er
!
!
W
W
O
O
N
N
y
y
bu
bu
to
to
k
k
lic
lic
C
C
w
w
m
m
w w
w
w
o
o
.d o .c .d o .c
c u -tr a c k c u -tr a c k
Powdered drug (1 g) is extracted with 10 ml methanol for 15 min 011 a water bath; 30 III of Cimidfugae
the filtrate is used for TLC. rhizoma
Powdered drug (l g) is extracted with chloroform for) h under reflux; 20 ul of the filtrate Ononidis
Is used for TLC of terpenes. radix
Powdered drug (I g) is extracted with 10 mlmethanol for 15 min on a water bath; 20 III is
used for TLC of flavonoid glycosides and terpenes.
Caffeic and ferulic acid; ononin, rutin, chlorogenic acid, hyperoside as a 0.1% solution in Reference
methanol; 10 ftl is used for TLC. solutions
16.3 Detection
PD
er
er
!
!
W
W
O
O
N
N
y
y
bu
bu
to
to
k
k
lic
lic
C
C
w
w
m
m
w w
w
w
o
o
.d o .c .d o .c
c u -tr a c k c u -tr a c k
336
16.5 Formulae
Cimlfugoside R = Xylose
Cimicigenol R~H
h a n g e Vi h a n g e Vi
XC e XC e
F- w F- w
PD
PD
er
er
!
!
W
W
O
O
N
N
y
y
bu
bu
to
to
k
k
lic
lic
C
C
w
w
m
m
w w
w
w
o
o
.d o .c .d o .c
c u -tr a c k c u -tr a c k
RD
Actein R ~ Xylose
Acetyl-acteol R~H
o-Onocerln (~Onocol)
Ononin R ~ Glucose
Formononetin R~H
h a n g e Vi h a n g e Vi
XC e XC e
F- w F- w
PD
PD
er
er
!
!
W
W
O
O
N
N
y
y
bu
bu
to
to
k
k
lic
lic
C
C
w
w
m
m
w w
w
w
o
o
.d o .c .d o .c
c u -tr a c k c u -tr a c k
338
16.6 Chromatograms
Cimicifugae rhizoma
j1ig.IA In UV-254 nm Cimidfugae rhizoma (l) shows two prominent quenching zones at R,
0.55-0.65 due to caffeic acid (TI) and the isoflavone formononetin (1'2). The zones at
It, 0.05-0.1 are phenol carboxylic acids.
n After treatment with the NST/PEG reagent, the main zones develop a bright blue
fluorescence in UV-365 nrn.
c Treatment with AS reagent reveals the violet zones of the trlterpene glycosides in the R,
range 0.3-0.55. The prominent zones arc due to actein and clmifugoside.
Ononidis radix
PD
er
er
!
!
W
W
O
O
N
N
y
y
bu
bu
to
to
k
k
lic
lic
C
C
w
w
m
m
w w
w
w
o
o
.d o .c .d o .c
c u -tr a c k c u -tr a c k
-F
Rf
-0.5
-s
T1 12 11 12 Fig. I
-F
Rf
11 12 T1 Fig. 2